Suppr超能文献

大鼠肝脏血管加压素受体与鸟嘌呤核苷酸结合蛋白及磷脂酰肌醇特异性磷脂酶C形成复合物的增溶作用。

Solubilization of rat liver vasopressin receptors as a complex with a guanine-nucleotide-binding protein and phosphoinositide-specific phospholipase C.

作者信息

Aiyar N, Bennett C F, Nambi P, Valinski W, Angioli M, Minnich M, Crooke S T

机构信息

Department of Molecular Pharmacology, Smith Kline and French Laboratories, Philadelphia, PA 19101.

出版信息

Biochem J. 1989 Jul 1;261(1):63-70. doi: 10.1042/bj2610063.

Abstract

Vasopressin V1 receptors were solubilized from rat liver plasma membranes with the detergent lysophosphatidylcholine. [[3H]Arginine]vasopressin (AVP) binding to the solubilized preparations was specific and saturable, with a dissociation constant of 0.6 nM. Cross-linking of [125I]vasopressin to the solubilized fraction, studied by SDS/polyacrylamide-gel-electrophoretic analysis, demonstrated the presence of a 65 kDa band which was specifically labelled with [125I]vasopressin. Specific binding of [3H]AVP to these solubilized receptors was decreased by guanine nucleotides, but not by adenosine 5'-[beta gamma-imido]triphosphate. Addition of vasopressin increased specific binding of 35S-labelled guanosine 5'-[gamma-thio]triphosphate (GTP[35S]) to the solubilized fractions, indicating co-solubilization of GTP-binding protein(s) [G-protein(s)] and vasopressin receptors. The solubilized fraction was insensitive to both cholera- and pertussistoxin treatment. Immunoblotting of the solubilized fraction with antibodies specific for a phosphoinositide-specific phospholipase C (PI-PLC I) demonstrated the presence of a 60 kDa protein. Anti-PI-PLC I antiserum immunoprecipitated solubilized vasopressin-binding sites from rat liver (V1), but not solubilized vasopressin-binding sites from hog kidney (V2). Similar results were obtained with an anti-PI-PLC I IgG affinity column. The solubilized (V1) receptors were enriched by ion-exchange and high-performance gel-filtration liquid chromatography. Vasopressin-binding activity was co-eluted with PI-PLC I and GTP[S]-binding activity on a DEAE-Sepharose column. The major vasopressin- and GTP[35S]-binding activities were co-eluted with PI-PLC I activity at approx. 240 kDa suggesting that vasopressin receptors from rat liver membranes can be solubilized as a complex of receptor-coupler-effector by using the detergent lysophosphatidycholine.

摘要

用去污剂溶血磷脂酰胆碱从大鼠肝细胞膜中溶解血管加压素V1受体。[³H]精氨酸血管加压素(AVP)与溶解制剂的结合具有特异性和饱和性,解离常数为0.6 nM。通过SDS/聚丙烯酰胺凝胶电泳分析研究[¹²⁵I]血管加压素与溶解部分的交联,结果显示存在一条65 kDa的条带,该条带被[¹²⁵I]血管加压素特异性标记。鸟嘌呤核苷酸可降低[³H]AVP与这些溶解受体的特异性结合,但5'-[βγ-亚氨基]三磷酸腺苷则无此作用。添加血管加压素可增加³⁵S标记的鸟苷5'-[γ-硫代]三磷酸(GTP[³⁵S])与溶解部分的特异性结合,表明GTP结合蛋白(G蛋白)与血管加压素受体共溶解。溶解部分对霍乱毒素和百日咳毒素处理均不敏感。用针对磷脂酰肌醇特异性磷脂酶C(PI-PLC I)的抗体对溶解部分进行免疫印迹分析,结果显示存在一种60 kDa的蛋白质。抗PI-PLC I抗血清可免疫沉淀大鼠肝脏(V1)中溶解的血管加压素结合位点,但不能沉淀猪肾中溶解的血管加压素结合位点(V2)。用抗PI-PLC I IgG亲和柱也得到了类似结果。通过离子交换和高效凝胶过滤液相色谱法富集溶解的(V1)受体。在DEAE-琼脂糖柱上,血管加压素结合活性与PI-PLC I和GTP[³⁵S]结合活性共洗脱。主要的血管加压素和GTP[³⁵S]结合活性在约240 kDa处与PI-PLC I活性共洗脱,这表明使用去污剂溶血磷脂酰胆碱可将大鼠肝细胞膜中的血管加压素受体作为受体-偶联物-效应器复合物溶解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/86d7/1138781/4326ee2a1407/biochemj00204-0069-a.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验